Journal article
Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study
Paul K Drain, Lilishia Gounder, Anneke Grobler, Faieza Sahid, Ingrid V Bassett, Mahomed-Yunus S Moosa
BMJ OPEN | BMJ PUBLISHING GROUP | Published : 2015
Grants
Awarded by Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University
Awarded by Program in AIDS Clinical Research Training Grant
Awarded by National Institute of Allergy and Infectious Disease
Awarded by Harvard University Center for AIDS Research
Awarded by National Institute of Mental Health
Funding Acknowledgements
This study was funded by the Medical Research Council of South Africa, the Howard Hughes Medical Institute, the KwaZulu-Natal Research Institute for TB and HIV (K-RITH), and the UK's Department for International Development. Dr Drain was supported by the Harvard Global Health Institute, the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988), the Infectious Disease Society of America Education & Research Foundation (IDSA ERF) and National Foundation for Infectious Diseases (NFID), The Program in AIDS Clinical Research Training Grant (T32 AI007433), the National Institute of Allergy and Infectious Disease (K23 AI108293), the Harvard University Center for AIDS Research (P30 AI060354) and the Massachusetts General Hospital Executive Committee on Research. Dr Bassett was supported by the National Institute of Mental Health R01 MH090326 (IVB) and the Claflin Distinguished Scholar Award (IVB).